Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Oct, 21 2025
Oct, 12 2025
Nov, 9 2025
Dec, 16 2025
Dec, 11 2025